Endocardial Changes in Nonvalvular Atrial Fibrillation Without Atrial Thrombus-Thrombomodulin and Tissue Factor

Kang An1, Ju Mei2, Jiaquan Zhu2

  • 11 Department of Surgery, National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.

Insights

Atrial fibrillation (AF) is linked to reduced thrombomodulin (TM) expression in the heart

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Background:

  • Atrial fibrillation (AF) is a primary cause of thromboembolism.
  • Mechanisms include blood stasis and hypercoagulability, but endocardial changes are less understood.
  • Endocardial alterations may influence local coagulation and thrombus formation in AF.

Purpose of the Study:

  • To investigate endocardial changes in nonvalvular AF.
  • To assess the expression of thrombomodulin (TM) and tissue factor pathway inhibitor (TFPI) in AF patients.
  • To explore the relationship between these markers and left atrial diameter (LAD).

Main Methods:

  • Left atrial appendage samples were collected from nonvalvular AF and non-AF patients.
  • Immunohistochemistry was used to semiquantitatively grade TM and TFPI expression.
  • Statistical analysis compared marker expression and LAD between groups.

Main Results:

  • Decreased TM expression was observed in nonvalvular AF patients compared to controls (P < .001).
  • No significant difference in TFPI expression was found between AF and non-AF groups (P = .213).
  • Lower TM scores correlated with larger left atrial diameter (LAD) (P = .009).

Conclusions:

  • Nonvalvular AF is associated with reduced atrial endocardial TM expression.
  • TFPI expression remains unchanged in AF patients without thrombus.
  • Downregulated TM may be linked to enlarged LAD in AF.

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
625
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Factors Affecting Drug Distribution: Tissue Permeability01:30

Factors Affecting Drug Distribution: Tissue Permeability

The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
702